Citigroup’s Zomedica Corp. ZOM Stock Holding History
Bought
Maintained
Sold
Other funds holding ZOM
AA
BCI
OPS
ASN
SWM
PRTG
JWM
GJIA
PCIA
Citigroup's ZOM Position: Q1 2025 in Review
Citigroup sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 9,966 shares — an estimated $1.2K sold.
Citigroup first reported a position in ZOM in Q2 2018 and held it in 23 quarters. The position peaked at $339K in Q2 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.
- Citigroup reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
- Citigroup sold 9,966 Zomedica Corp. shares in Q1 2025, an estimated $1.2K.
- Citigroup first reported a position in Zomedica Corp. in Q2 2018 and held it in 23 quarters.
- Citigroup's Zomedica Corp. position peaked at $339K in Q2 2021.
- 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.